Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16260
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, LY-
dc.contributor.authorWong, Anselm-
dc.contributor.authorRobertson, T-
dc.contributor.authorBurns, K-
dc.contributor.authorRoberts, M-
dc.contributor.authorIsbister, Geoffrey K-
dc.date2016-07-14-
dc.date.accessioned2016-09-14T04:17:08Z-
dc.date.available2016-09-14T04:17:08Z-
dc.date.issued2017-03-
dc.identifier.citationJournal of Medical Toxicology 2017; 13(1): 88-90en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16260-
dc.description.abstractThe objective of this case is to describe the pharmacokinetics and toxicity of midodrine in overdose. A 20 year old female ingested up to 350 mg midodrine while recovering in hospital from another overdose. She developed vomiting and severe hypertension (blood pressure [BP], 210/100 mmHg). Remarkable findings included a heart rate with a range of 43-60 beats/min, spontaneous respirations (20 breaths/min), and oxygen saturations of >95 % on FiO2 25 %, and a GS of 8. She was admitted to intensive care and had a normal non-contrast CT brain. She was treated with a glyceryl trinitrate patch (5 mg) and observed for 36 h with subsequent BP reduction to 124/81 mmHg and improved in conscious state. Midodrine and desglymidodrine concentrations were measured with liquid chromatography tandem mass spectrometry and were detected with 2-h post-ingestion at concentrations of 158.4 and 169.7 ng/mL, respectively. The parent drug concentrations rapidly decreased with an elimination of half-life of 1.6 h, and the metabolite initially increased and then decreased. The peak in blood pressure appeared to coincide with peak metabolite concentrations. Midodrine in overdose can potentially cause severe hypertension and reflex bradycardia but given its short half-life treatment with vasodilator agents and supportive care is sufficient.en_US
dc.subjectAntihypotensiveen_US
dc.subjectOrthostatic hypotensionen_US
dc.subjectPoisoningen_US
dc.subjectVasopressoren_US
dc.titleSevere hypertension and bradycardia secondary to midodrine overdoseen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Medical Toxicologyen_US
dc.identifier.affiliationVictorian Poisons Information Centreen_US
dc.identifier.affiliationSchool of Clinical Sciences, Monash University, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Surgery, University of Melbourne, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australiaen_US
dc.identifier.affiliationClinical Toxicology Research Group, University of Newcastle, Newcastle, NSW, Australiaen_US
dc.identifier.affiliationToxicologyen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27417951en_US
dc.identifier.doi10.1007/s13181-016-0574-4en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherWong, Anselm Y
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptToxicology-
crisitem.author.deptEmergency-
crisitem.author.deptVictorian Poisons Information Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Nov 13, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.